Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novabay Pharmaceuticals
(NY:
NBY
)
0.0824
-0.0016 (-1.90%)
Official Closing Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,606,719
Open
0.0838
Bid (Size)
0.0801 (10)
Ask (Size)
0.0820 (30)
Prev. Close
0.0840
Today's Range
0.0777 - 0.0860
52wk Range
0.0711 - 1.950
Shares Outstanding
30,098,150
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
April 17, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
March 26, 2024
NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
-57.66%
-57.66%
1 Month
-40.29%
-40.29%
3 Month
-45.79%
-45.79%
6 Month
-77.74%
-77.74%
1 Year
-95.12%
-95.12%
More News
Read More
NovaBay Pharmaceuticals: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
March 26, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Recap: NovaBay Pharmaceuticals Q3 Earnings
November 09, 2023
Via
Benzinga
Earnings Preview For NovaBay Pharmaceuticals
November 08, 2023
Via
Benzinga
Earnings Scheduled For March 26, 2024
March 26, 2024
Via
Benzinga
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
March 25, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
March 14, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 06, 2024
Via
Benzinga
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
January 30, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
January 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 29, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
January 26, 2024
Via
Benzinga
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
January 09, 2024
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
January 09, 2024
Via
ACCESSWIRE
NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
December 06, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
November 30, 2023
Via
Benzinga
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
November 02, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
October 11, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
October 02, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
September 14, 2023
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.